Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 280

1.

Pneumocystis jirovecii pneumonia in systemic lupus erythematosus from southern Taiwan.

Weng CT, Liu MF, Weng MY, Lee NY, Wang MC, Lin WC, Ou CY, Lai WW, Hsu SC, Chao SC, Chung TJ, Lee CT, Shieh CC, Wang JY, Wang CR.

J Clin Rheumatol. 2013 Aug;19(5):252-8. doi: 10.1097/RHU.0b013e31829d5017.

PMID:
23872548
2.
3.

Pneumocystis jiroveci pneumonia in giant cell arteritis: A case series.

Kermani TA, Ytterberg SR, Warrington KJ.

Arthritis Care Res (Hoboken). 2011 May;63(5):761-5. doi: 10.1002/acr.20435.

4.

Clinical significance of positive Pneumocystis jirovecii polymerase chain reaction in non-human immunodeficiency virus immunocompromised patients in a real practice.

Lee HY, Kang HS, Lee HY, Rhee CK, Lee SY, Kim SC, Kim SJ, Park YJ, Kim YK, Kang JY.

Korean J Intern Med. 2017 May;32(3):478-485. doi: 10.3904/kjim.2015.340. Epub 2016 Dec 13.

5.

[An epidemiologic study on Pneumocystis pneumonia in non-HIV infected patients in China].

Sun L, Huang MJ, An YJ, Guo ZZ.

Zhonghua Liu Xing Bing Xue Za Zhi. 2009 Apr;30(4):348-51. Chinese.

PMID:
19731525
6.

[Positive Pneumocystis jirovecii PCR in immunocompromised patients with a systemic disease: infection or colonisation?].

Mekinian A, Queyrel V, Durand-Joly I, Moranne O, Denis G, Delhaes L, Morell-Dubois S, Lambert M, Launay D, Hachulla E, Hatron PY.

Rev Med Interne. 2010 Mar;31(3):194-9. doi: 10.1016/j.revmed.2009.11.007. Epub 2009 Dec 31. French.

PMID:
20045225
7.

High prevalence of dihydropteroate synthase mutations in Pneumocystis jirovecii isolated from patients with Pneumocystis pneumonia in South Africa.

Dini L, du Plessis M, Frean J, Fernandez V.

J Clin Microbiol. 2010 Jun;48(6):2016-21. doi: 10.1128/JCM.02004-09. Epub 2010 Mar 29.

8.

Outcome of Pneumocystis jirovecii pneumonia diagnosed by polymerase chain reaction in patients without human immunodeficiency virus infection.

Hardak E, Neuberger A, Yigla M, Berger G, Finkelstein R, Sprecher H, Oren I.

Respirology. 2012 May;17(4):681-6. doi: 10.1111/j.1440-1843.2012.02158.x.

PMID:
22390188
9.

Degree and frequency of inhibition in a routine real-time PCR detecting Pneumocystis jirovecii for the diagnosis of Pneumocystis pneumonia in Turkey.

Döskaya M, Caner A, Degirmenci A, Wengenack NL, Yolasigmaz A, Turgay N, Ozensoy Töz S, Gürüz Y.

J Med Microbiol. 2011 Jul;60(Pt 7):937-44. doi: 10.1099/jmm.0.030775-0. Epub 2011 Apr 1.

PMID:
21459903
10.

Use of different primer directed sequence amplification by polymerase chain reaction for identification of Pneumocystis jirovecii in clinical samples.

Gupta R, Mirdha BR, Guleria R, Mohan A, Kabra SK, Kumar L, Agarwal SK, Luthra K.

Indian J Chest Dis Allied Sci. 2008 Oct-Dec;50(4):321-7.

PMID:
19035050
11.

Use of Induced sputum to determine the prevalence of Pneumocystis jirovecii in immunocompromised children with pneumonia.

Das CK, Mirdha BR, Singh S, Seth R, Bagga A, Lodha R, Kabra SK.

J Trop Pediatr. 2014 Jun;60(3):216-22. doi: 10.1093/tropej/fmt112. Epub 2014 Jan 13.

PMID:
24425204
12.

Underlying renal insufficiency: the pivotal risk factor for Pneumocystis jirovecii pneumonia in immunosuppressed patients with non-transplant glomerular disease.

Ye WL, Tang N, Wen YB, Li H, Li MX, Du B, Li XM.

Int Urol Nephrol. 2016 Nov;48(11):1863-1871. Epub 2016 Jun 28.

PMID:
27351666
13.

[Clinical characteristics of Pneumocystis carinii pneumonia in children with systemic lupus erythematosus].

Tang XY, Li J, Dong F, Song HM.

Zhonghua Er Ke Za Zhi. 2013 Dec;51(12):920-4. Chinese.

PMID:
24495763
14.

Pneumocystis jirovecii pneumonia in patients with and without human immunodeficiency virus infection.

Su YS, Lu JJ, Perng CL, Chang FY.

J Microbiol Immunol Infect. 2008 Dec;41(6):478-82.

PMID:
19255691
15.

Pneumocystis polymerase chain reaction and blood (1→3)-β-D-glucan assays to predict survival with suspected Pneumocystis jirovecii pneumonia.

Matsumura Y, Ito Y, Yamamoto M, Matsushima A, Nagao M, Takakura S, Iinuma Y, Ichiyama S.

J Infect Chemother. 2014 Feb;20(2):109-14. doi: 10.1016/j.jiac.2013.09.004. Epub 2013 Dec 11.

PMID:
24480550
16.

Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients.

Mühlethaler K, Bögli-Stuber K, Wasmer S, von Garnier C, Dumont P, Rauch A, Mühlemann K, Garzoni C.

Eur Respir J. 2012 Apr;39(4):971-8. doi: 10.1183/09031936.00095811. Epub 2011 Sep 15.

17.

High prevalence of Pneumocystis jirovecii colonization among patients with autoimmune inflammatory diseases and corticosteroid therapy.

Fritzsche C, Riebold D, Munk-Hartig A, Klammt S, Neeck G, Reisinger E.

Scand J Rheumatol. 2012 May;41(3):208-13. doi: 10.3109/03009742.2011.630328. Epub 2012 Mar 9.

PMID:
22400983
18.

Pneumocystis jirovecii pneumonia in mycophenolate mofetil-treated patients with connective tissue disease: analysis of 17 cases.

Zhang Y, Zheng Y.

Rheumatol Int. 2014 Dec;34(12):1765-71. doi: 10.1007/s00296-014-3073-4. Epub 2014 Jun 20.

PMID:
24948376
19.

High Pneumocystis jirovecii colonization rate among haemodialysis patients.

Fritzsche C, Ghanem H, Koball S, Mueller-Hilke B, Reisinger EC.

Infect Dis (Lond). 2017 Feb;49(2):132-136. Epub 2016 Sep 29.

PMID:
27684384
20.

Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1->3)-β-D-glucan for differential diagnosis of pneumocystis pneumonia and Pneumocystis colonization.

Damiani C, Le Gal S, Da Costa C, Virmaux M, Nevez G, Totet A.

J Clin Microbiol. 2013 Oct;51(10):3380-8. doi: 10.1128/JCM.01554-13. Epub 2013 Jul 31.

Supplemental Content

Support Center